The combination heart failure drug sacubitril/valsartan is well-covered under Medicare Part D plans, according to a recent analysis, but patient access to the medication remains limited by steep out-of-pocket costs than can exceed $1,600 annually.
Just three categories of diagnostic errors account for roughly 75% of all serious misdiagnosis-related harms to patients, according to a new study published in Diagnosis.
Spontaneous coronary artery dissection is emerging from the shadows as an important cause of myocardial infarction in younger women. That visibility is leading to fundamental changes in how the condition is diagnosed and treated.
Preoperative breast MRI (pMRI) can improve the surgical management of patients with newly diagnosed pure ductal carcinoma in situ (DCIS), according to a new study published in Academic Radiology.
After introducing its new HealthHub concept store in Texas, CVS Health is spreading the store model to Boston, Dallas/Fort Worth, Maryland, North Carolina, Ohio and Virginia, the company announced.
The Affordable Care Act is back in court this week after a Texas judge ruled the law unconstitutional in late 2018, prompting the American Heart Association and other major societies to issue a joint statement supporting the ACA and its protections for patients with pre-existing conditions.